Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Eugenio Sanchez-López"'
Autor:
Sara Márquez-Rivero, Enrique Hermida-Campa, Compliance, Carmen Gracia-Diez, Nieves Martell-Claros, Eugenio Sanchez-López, Emilio Márquez-Contreras, Vicente Francisco Gil-Guillén
Publikováno v:
Current Medical Research and Opinion. 34:1301-1308
Objective To assess the efficacy of a mixed intervention, educational, and reminder calendar of the intake, as a strategy to improve therapeutic adherence with dabigatran in patients with non-valvular atrial fibrillation (NVAF). Methods This was a pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78692f40b7821ce19841663a40e8ae5f
https://doi.org/10.1080/03007995.2018.1435519
https://doi.org/10.1080/03007995.2018.1435519
Autor:
Nieves Martell-Claros, Ines Gil-Gil, Emilio Márquez-Contreras, Eugenio Sanchez-López, Vicente Francisco Gil-Guillén, Mariano De La Figuera-Von Wichmann, Sara Márquez-Rivero
Publikováno v:
QUALITY OF LIFE RESEARCH
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto de Salud Carlos III (ISCIII)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto de Salud Carlos III (ISCIII)
To assess the quality of life (QOL) with rivaroxaban in patients with non-valvular atrial fibrilation (NVAF) related to therapeutic compliance. Prospective, longitudinal, multicenter study was developed in 160 Spanish primary or specialized care cent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20fd3b613cbf1b50093714267ddd5249
https://doi.org/10.1007/s11136-016-1489-x
https://doi.org/10.1007/s11136-016-1489-x
Autor:
Ines Gil-Gil, Eugenio Sanchez-López, Sara Márquez-Rivero, Nieves Martell-Carlos, Mariano De La Figuera-Von Wichmann, Compliance, Enrique Hermida-Campa, Vincente Gil-Guillén, Emilio Márquez-Contreras
Publikováno v:
Current medical research and opinion. 32(12)
To assess compliance with treatment with rivaroxaban in patients with non-valvular atrial fibrillation.Prospective, longitudinal, multicenter study, developed in 160 Spanish primary or specialized care centers. We included 412 patients treated with r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcddac800d5e50efefb17e311cd13694
https://pubmed.ncbi.nlm.nih.gov/27548637
https://pubmed.ncbi.nlm.nih.gov/27548637